Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04994015 · ClinicalTrials.gov registry record
Parkinson's Foundation PD GENEration Genetic Registry
A clinical trial of Parkinson's Disease, sponsored by Parkinson's Foundation.
- Recruiting
- Registry status
- 25,000
- Enrollment target
- 20
- Study locations
NCT04994015: Recruiting study of Parkinson's Disease, sponsored by Parkinson's Foundation.
NCT04994015 is a study of Parkinson's Disease that is actively recruiting participants, run by Parkinson's Foundation. The registered enrollment target is 25,000 participants, above the 477-participant average among 158 other Parkinson's Disease trials with a reported enrollment target (5141% higher). The trial reports 20 study locations across 10 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04994015, a study of Parkinson's Disease, is actively recruiting participants, sponsored by Parkinson's Foundation.
- RECRUITING
- Registry status
- 25,000 participants
- Enrollment target
- 20
- Study locations
Study Summary
Development of a central repository for PD-related genomic data for future research.
Primary Outcome
Identify people with Parkinson's who have genetic mutations to advance basic science and clinical research.
Conditions Studied
Interventions
- DEVICE Lab Assay for seven genetic variants for Parkinson's Disease
Study Locations (20)
Florida
- Aventura Neurology - Visionary Investigators Network - Aventura
- Parkinson's Disease & Movement Disorder Center of Boca Raton - Boca Raton
- University of Florida - Gainesville
- University of Miami - Miami
- Cleveland Clinic Weston - Weston
Illinois
- University of Illinois-Chicago - Chicago
- Rush University - Chicago
- University of Chicago - Chicago
- Northwestern University - Evanston
California
- University of California San Diego (UCSD) - La Jolla
- University of California Los Angeles - Los Angeles
- University of California San Francisco (UCSF) - San Francisco
Arizona
- MD First Research - Chandler
- Barrow Neurological Institute - Phoenix
Alabama
- University of Alabama Birmingham - Birmingham
Arkansas
- University of Arkansas - Fayetteville
Colorado
- University of Colorado Anschutz - Aurora
Connecticut
- Hartford Healthcare - Hartford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25,000 participants |
| Start Date | 2020-12-20 |
| Est. Completion | 2026-07-01 |
What NCT04994015 shows while recruiting
NCT04994015 is an observational study that tracks outcomes without assigning an intervention. Its 25,000 participants enrollment target places it among the larger protocols in the corpus, above the 477-participant average among 158 other Parkinson's Disease trials with a reported enrollment target (5141% higher).
The record links to 1 condition, with Parkinson's Disease appearing as the primary indexed condition, and to 1 intervention - of which Lab Assay for seven genetic variants for Parkinson's Disease is the first listed.
NCT04994015 names 20 study sites across 10 states, led by Florida, Illinois, California.
Frequently Asked Questions
What is clinical trial NCT04994015 about?
NCT04994015 is a clinical study titled "Parkinson's Foundation PD GENEration Genetic Registry". Development of a central repository for PD-related genomic data for future research.
What is the current status of trial NCT04994015?
This trial is currently recruiting. The enrollment target is 25,000 participants. The study started on 2020-12-20. Estimated completion is 2026-07-01.
What conditions does trial NCT04994015 study?
This clinical trial studies the following conditions: Parkinson's Disease.
What interventions are being tested in trial NCT04994015?
The interventions under investigation include: Lab Assay for seven genetic variants for Parkinson's Disease (DEVICE).
Who is sponsoring clinical trial NCT04994015?
This trial is sponsored by Parkinson's Foundation, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04994015 being conducted?
This trial has 20 study locations across Alabama, Arizona, Arkansas, California, Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Parkinson's Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04994015's enrollment target sits among peer trials
25,000 1st of 158 the highest of 158 other Parkinson's Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Parkinson's Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Novel DBS Stimulation Patterns for Treatment of Parkinson's Disease
RECRUITING · NA
-
rTMS to Improve Cognition in Parkinson's
RECRUITING · Phase 1
-
Deep Brain Stimulation for Visuomotor Function in Parkinson's Disease
RECRUITING
-
Ketamine for Veterans With Parkinson's Disease
RECRUITING · Phase 2
-
Feasibility and Safety of a Portable Exoskeleton to Improve Mobility in Parkinson's Disease
RECRUITING · NA
-
PET Imaging Evaluation of [11C]SY08
RECRUITING · Early Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04595201 · 25,000 participants
Clinical Follow-up of Pregnant Subjects Undergoing NIPT
- NCT06589310 · 25,000 participants
Falcon Real World Evidence Registry
- NCT06773897 · 25,000 participants
Rutgers University Study of the Genetics of Breast Cancer.
- NCT06774417 · 25,000 participants · NA
Digital Strategies to Advance Help-Seeking - Aim 3
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI